Yahoo
    NasdaqGS - Nasdaq Real Time Price USD

    Carlsmed, Inc. (CARL)

    14.95 -0.82 (-5.20%)
    At close: October 30 at 4:00:01 PM EDT
    15.00 +0.05 (+0.33%)
    After hours: October 30 at 5:10:34 PM EDT
    Trade CARL on Coinbase
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for CARL
    Chart does not reflect overnight price.
    • Previous Close 15.77
    • Open 15.80
    • Bid 11.36 x 200
    • Ask 19.32 x 200
    • Day's Range 14.85 - 15.89
    • 52 Week Range 8.50 - 17.23
    • Volume 73,279
    • Avg. Volume 111,579
    • Market Cap (intraday) 408.176M
    • Beta (5Y Monthly) --
    • PE Ratio (TTM) --
    • EPS (TTM) -1.08
    • Earnings Date Nov 10, 2026
    • Forward Dividend & Yield -- (0.00%)
    • 1y Target Est 19.40
    • Zacks Rating Neutral

    Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

    carlsmed.com

    127

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Health Information Services

    Industry

    More about Carlsmed, Inc.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

    YTD Return

    CARL
    21.05%
    S&P 500 (^GSPC)
    10.73%

    1-Year Return

    CARL
    17.62%
    S&P 500 (^GSPC)
    11.11%

    3-Year Return

    CARL
    0.33%
    S&P 500 (^GSPC)
    81.91%

    5-Year Return

    CARL
    0.33%
    S&P 500 (^GSPC)
    64.59%

    Earnings Trends

    View More

    Earnings Per Share

    GAAP
    Normalized
    GAAP
    Normalized

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q2 FY26
    Revenue 18.94M
    Earnings -10.51M
    Profit Margin -55.49%

    Q3

    FY25

    Q4

    FY25

    Q1

    FY26

    Q2

    FY26

    -10M
    0
    10M
    -64.0%
    -62.0%
    -60.0%
    -58.0%
    -56.0%
    -54.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    17.00
    19.40 Average
    14.95 Current
    24.00 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell

    Latest Rating

    Date 10/12/2026
    Analyst BTIG
    Rating Action Maintains
    Rating Buy
    Price Action Raises
    Price Target 23 -> 24
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      -57.42%

    • Return on Assets (ttm)

      -28.19%

    • Return on Equity (ttm)

      -66.14%

    • Revenue (ttm)

      63.3M

    • Net Income Avi to Common (ttm)

      -36.34M

    • Diluted EPS (ttm)

      -1.08

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      89.22M

    • Total Debt/Equity (mrq)

      26.01%

    • Levered Free Cash Flow (ttm)

      -26.41M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    HTFL
    KMTS
    BBNX
    PRMB
    CBLL
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: